Connection

ALAN SWANN to Excitatory Amino Acid Antagonists

This is a "connection" page, showing publications ALAN SWANN has written about Excitatory Amino Acid Antagonists.
Connection Strength

0.280
  1. Valproate prevents the induction and the expression of MK-801 sensitization. Brain Res. 2002 Nov 08; 954(2):151-9.
    View in: PubMed
    Score: 0.045
  2. Disruption of sensitization to methylphenidate by a single administration of MK-801. Life Sci. 2002 Mar 29; 70(19):2271-85.
    View in: PubMed
    Score: 0.044
  3. The role of MK-801 in sensitization to stimulants. Brain Res Brain Res Rev. 2001 Apr; 35(2):97-114.
    View in: PubMed
    Score: 0.041
  4. Blockade of sensitization to methylphenidate by MK-801: partial dissociation from motor effects. Neuropharmacology. 2001; 40(2):298-309.
    View in: PubMed
    Score: 0.040
  5. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate. Brain Res Bull. 2000 Apr; 51(6):485-92.
    View in: PubMed
    Score: 0.038
  6. Dose-related effects of MK-801 on acute and chronic methylphenidate administration. Brain Res. 1998 Dec 14; 814(1-2):78-85.
    View in: PubMed
    Score: 0.035
  7. Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches. Curr Psychiatry Rep. 2015 Oct; 17(10):81.
    View in: PubMed
    Score: 0.028
  8. NMDA receptor antagonist disrupts acute and chronic effects of methylphenidate. Physiol Behav. 2000 Oct 1-15; 71(1-2):133-45.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.